Pfizer - Sayana Press

LMIC access to all-in-one injectable contraceptive

Pfizer received foundation support to expand access to Sayana, the pharmaceutical company’s all-in-one injectable contraceptive, giving women in the developing world an affordable option.
  • Domain
  • Investment type
    Volume guarantee
  • Status
    Active
  • Initial investment
    Public
  • Partnered in
    2017
  • Investment lead
    Natalie Revelle
  • Headquarters
    USA
  • Program strategy
    Family Planning

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.